Related Articles
The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells
A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells Corrigendum in /10.3892/ol.2020.11303
Antitumor effects of a drug combination targeting glycolysis, glutaminolysis and de novo synthesis of fatty acids
INVIVO CONTROL OF TUMOR-GROWTH BY LONIDAMINE AND RADIATIONS - INFLUENCE OF THE TIMING AND SEQUENCE OF DRUG ADMINISTRATION AND IRRADIATION TREATMENT
CLINICAL MODULATION OF EPIRUBICIN RESISTANCE BY LONIDAMINE IN PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMAS